期刊文献+

咪唑普利对高血压患者血压及有关生化因素的影响 被引量:1

Effect of Imidapril on blood pressure and associated metabolic changes in hypertensive patients
下载PDF
导出
摘要 目的 评估ACEI咪唑普利(Imidapril)对原发性高血压患者的降压效果及对有关因素(包括血脂、内皮素等)的影响。方法 选择31例高血压患者服用咪唑普利5~10mg/日,连续4~6周,观察比较服药前后血压、心率、生化指标及内皮素含量。结果 服药后血压、心率、TC、LDL-C及内皮素显著降低,血肌酐及其它指标无明显变化。结论 咪唑普利具有良好的降压效果,无反射性心率加快,对血脂、血糖无不良影响,并能降低内皮素含量。 Objective To evaluate the effects of imidapril on blood pressure and the associated metabolic changes (Lipemia, endothelin, etc. ). Methods 31 patients with essential hypertensive were treatad by imidapril (5-0mg/d), after 4 - 6 weeks the change of blood pressme, heart rate, blood biochemistry and endothelin was inveatigated, and compared with them before treatment. Results The imidapril not only markedly decreased blood pressure but also decreased plasma endothelin levels, plasma cholesterol and LDL - C, etc. Conclusion Imidapril can markedly decrease blood pressure and plasma endothelin, has no abnormal effects on associated metabolic factors.
出处 《实用心脑肺血管病杂志》 1999年第1期21-23,共3页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 高血压 咪唑普利 血脂 内皮素 Hyperfension Imidapril Lipemia Endothelin
  • 相关文献

同被引文献27

  • 1姜洪,李云良.抗高血压药物对血脂代谢的影响[J].福建医药杂志,1990,12(1):41-42. 被引量:2
  • 2王强.莫索尼定不影响血脂及低密度脂蛋白亚型[J].中国医学论坛报,2000,26(19):14-14.
  • 3Macleod MJ, Mclay J. Drug treatment of hypertension complicating diabetes mellitus [ J ]. Drugs, 1998, 56(2): 189-202.
  • 4Tamasawa N, Matsui J, Ogawa Y, et al. Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension [ J ]. Diabetes Complications, 2000,14(3) :135-139.
  • 5Totsuka M, Miyashita Y, Ito Y, et al. The effect of celiprolol hydrochloride for lipid metabolism-especially for the low density lipoprotein particle size [ J ].Nippon Ronen Igakkai Zasshi, 2001,38(3) :352-359.
  • 6Noguchi N, Nishino K, Niki E. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation[ J ]. Biochem Pharmacol, 2000, 59(9) :1069-1076.
  • 7Pressel S, Davis BR, Louis G T, et al. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ( ALLHAT) [J]. Control Clin Trials, 2001,22(6): 674-686.
  • 8Ahaneku JE, Sakata K, Urano T, et al. Influence of baseline values on lipids,lipeproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients [ J ]. Pharmacol Res, 2001,41 ( 1 ): 75-79.
  • 9Ashida T. Treatment of hypertension with dyslipidemia [ J ]. Nippon Rinsho,2001,59 (5) :978-982.
  • 10Sanz M, Ganado P, Tejerina T. Two angiotensin AT1 receptor antagonists, irbesartan and losartan, effects in cholesterol-fed rabbits [ J ]. Eur J Pharmacol, 2002, 3:99-106.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部